These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20723006)

  • 21. Minalrestat, an aldose reductase inhibitor, corrects the impaired microvascular reactivity in diabetes.
    Akamine EH; Hohman TC; Nigro D; Carvalho MH; de Cássia Tostes R; Fortes ZB
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1236-42. PubMed ID: 12604701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of aldose reductase inhibitor on the inhibition of platelet aggregation induced by diabetic rat plasma.
    Takiguchi Y; Wada K; Nakashima M
    Eur J Pharmacol; 1992 May; 215(2-3):289-91. PubMed ID: 1396993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pyrido[1,2-a]pyrimidin-4-one derivatives as a novel class of selective aldose reductase inhibitors exhibiting antioxidant activity.
    La Motta C; Sartini S; Mugnaini L; Simorini F; Taliani S; Salerno S; Marini AM; Da Settimo F; Lavecchia A; Novellino E; Cantore M; Failli P; Ciuffi M
    J Med Chem; 2007 Oct; 50(20):4917-27. PubMed ID: 17845019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of an aldose reductase inhibitor on gastroenteropathy in streptozotocin-diabetic rats.
    Oya M; Hosokawa M; Tsukada H; Fukuda K; Nakamura H; Tsukiyama K; Nagashima K; Fujimoto S; Yamada Y; Seino Y
    Diabetes Res Clin Pract; 2003 Nov; 62(2):69-77. PubMed ID: 14581143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression of N(ɛ)-carboxymethyl lysine.
    Kawai T; Takei I; Tokui M; Funae O; Miyamoto K; Tabata M; Hirata T; Saruta T; Shimada A; Itoh H
    J Diabetes Complications; 2010; 24(6):424-32. PubMed ID: 19716319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of an aldose reductase inhibitor on glomerular basement membrane anionic sites in streptozotocin-induced diabetic rats.
    Isogai S; Inokuchi T; Ohe K
    Diabetes Res Clin Pract; 1995 Nov; 30(2):111-6. PubMed ID: 8833631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An aldose reductase inhibitor, TAT, reduces ADP-induced platelet hyperaggregation in streptozotocin-induced diabetic rats with neuropathy.
    Hara T; Nakamura J; Koh N; Sakakibara F; Hamada Y; Sasaki H; Naruse K; Nakashima E; Takeuchi N; Inukai S
    J Lab Clin Med; 1995 Dec; 126(6):541-7. PubMed ID: 7490513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 6,7-Dihydroxy-4-phenylcoumarin as inhibitor of aldose reductase 2.
    Kato A; Kobayashi K; Narukawa K; Minoshima Y; Adachi I; Hirono S; Nash RJ
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5630-3. PubMed ID: 20805028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carboxymethylated pyridoindole antioxidants as aldose reductase inhibitors: Synthesis, activity, partitioning, and molecular modeling.
    Stefek M; Snirc V; Djoubissie PO; Majekova M; Demopoulos V; Rackova L; Bezakova Z; Karasu C; Carbone V; El-Kabbani O
    Bioorg Med Chem; 2008 May; 16(9):4908-20. PubMed ID: 18395454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ranirestat has a stronger inhibitory activity on aldose reductase and suppresses inflammatory reactions in high glucose-exposed endothelial cells.
    Ishibashi Y; Matsui T; Matsumoto T; Kato H; Yamagishi S
    Diab Vasc Dis Res; 2016 Jul; 13(4):312-5. PubMed ID: 27190083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of aldose reductase inhibition with epalrestat on diabetes-induced changes in rat isolated atria.
    Booth RJ; Hodgson WC
    Clin Exp Pharmacol Physiol; 1993 Apr; 20(4):207-13. PubMed ID: 8485921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of ONO-2235, an aldose reductase inhibitor, on muscarinic receptors and contractile response of the urinary bladder in rats with streptozotocin-induced diabetes.
    Kanda M; Eto K; Tanabe N; Sugiyama A; Hashimoto K; Ueno A
    Jpn J Pharmacol; 1997 Mar; 73(3):221-8. PubMed ID: 9127817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro inhibition of lens aldose reductase by (2-benzyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole-8-yl)-acetic acid in enzyme preparations isolated from diabetic rats.
    Djoubissie PO; Snirc V; Sotnikova R; Zurova J; Kyselova Z; Skalska S; Gajdosik A; Javorkova V; Vlkovicova J; Vrbjar N; Stefek M
    Gen Physiol Biophys; 2006 Dec; 25(4):415-25. PubMed ID: 17356233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary polyphenol quercetin protects rat hearts during reperfusion: enhanced antioxidant capacity with chronic treatment.
    Ikizler M; Erkasap N; Dernek S; Kural T; Kaygisiz Z
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):404-10. PubMed ID: 18065337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenolic marine natural products as aldose reductase inhibitors.
    Manzanaro S; Salva J; de la Fuente JA
    J Nat Prod; 2006 Oct; 69(10):1485-7. PubMed ID: 17067167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary sorbitol measurement and the effect of an aldose reductase inhibitor on its concentration in the diabetic state.
    Nakano I; Tsugawa T; Shinohara R; Watanabe F; Fujita T; Nagata M; Kato T; Himeno Y; Kobayashi T; Fujiwara K; Nagata M; Itoh M; Nagasaka A
    J Diabetes Complications; 2003; 17(6):337-42. PubMed ID: 14583178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and evaluation of rhodanine derivatives as aldose reductase inhibitors.
    Agrawal YP; Agrawal MY; Gupta AK
    Chem Biol Drug Des; 2015 Feb; 85(2):172-80. PubMed ID: 24903533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. (4-Oxo-2-thioxothiazolidin-3-yl)acetic acids as potent and selective aldose reductase inhibitors.
    Kucerova-Chlupacova M; Halakova D; Majekova M; Treml J; Stefek M; Soltesova Prnova M
    Chem Biol Interact; 2020 Dec; 332():109286. PubMed ID: 33038328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effects of Ganoderma applanatum on rat lens aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues.
    Jung SH; Lee YS; Shim SH; Lee S; Shin KH; Kim JS; Kim YS; Kang SS
    Phytother Res; 2005 Jun; 19(6):477-80. PubMed ID: 16114079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced nerve blood flow in diabetic rats: relationship to nitric oxide production and inhibition of aldose reductase.
    Tomlinson DR; Dewhurst M; Stevens EJ; Omawari N; Carrington AL; Vo PA
    Diabet Med; 1998 Jul; 15(7):579-85. PubMed ID: 9686698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.